Evidence map›Paper›PMID 40050956›Full record

ArticleAnimal microbiome2025

Interactions between gilthead seabream intestinal transcriptome and microbiota upon Enteromyxum leei infection: a multi-omic approach.

Socorro Toxqui-Rodríguez, Itziar Estensoro, Ricardo Domingo-Bretón, Raquel Del Pozo, Jaume Pérez-Sánchez, Detmer Sipkema, Ariadna Sitjà-Bobadilla, M Carla Piazzon

Abstract read
In one paragraph

Article in Animal microbiome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Stable In Vitro Cultivation of the MyxozoanPathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Socorro Toxqui-RodríguezFish Pathology Group, Instituto de Acuicultura Torre de la Sal (IATS, CSIC), Castellón, Spain.
Itziar EstensoroFish Pathology Group, Instituto de Acuicultura Torre de la Sal (IATS, CSIC), Castellón, Spain.
Ricardo Domingo-BretónNutrigenomics and Fish Endocrinology Group, Instituto de Acuicultura Torre de la Sal (IATS, CSIC), Castellón, Spain.
Raquel Del PozoFish Pathology Group, Instituto de Acuicultura Torre de la Sal (IATS, CSIC), Castellón, Spain.
Jaume Pérez-SánchezNutrigenomics and Fish Endocrinology Group, Instituto de Acuicultura Torre de la Sal (IATS, CSIC), Castellón, Spain.
Detmer SipkemaLaboratory of Microbiology, Wageningen University and Research, Wageningen, The Netherlands.
Ariadna Sitjà-BobadillaFish Pathology Group, Instituto de Acuicultura Torre de la Sal (IATS, CSIC), Castellón, Spain.
M Carla PiazzonFish Pathology Group, Instituto de Acuicultura Torre de la Sal (IATS, CSIC), Castellón, Spain. carla.piazzon@csic.es.

Funding

Agencia Estatal de Investigación PID2020-115070RA-I00Generalitat Valenciana CIAICO/2022/144Generalitat Valenciana GVA-THINKINAZUL/2021/022H2020 Marie Skłodowska-Curie Actions 956697Ministerio de Ciencia e Innovación ThinkInAzul, PRTR-C17·I1
6 · The paper itself

Abstract

backgroundThe enteric myxozoan parasite Enteromyxum leei is an important problem in gilthead seabream aquaculture invading the intestinal epithelium and leading to chronic intestinal inflammation, poor food conversion rates, cachexia, and mortalities, with no treatments available, resulting in significant economic losses. It is known that myxozoan infections are affected by factors such as temperature, duration of exposure, stocking densities, and seasonality. Gut microbiota has key effects on host health, including disease resistance and immune system training and development, tightly interacting with the host, affecting systemic and local physiological functions. This study aimed to gain insights into the host-microbiota-parasite interactions integrating metataxonomics, host transcriptomics, and metatranscriptomics within this disease model.

resultsExposure to E. leei together with temperature and age differences led to alterations in gilthead seabream intestinal microbiota. Samples from 240 g fish kept at 18ºC during a winter trial at 10 weeks post-parasite exposure showed the highest significant changes in their microbial composition with Proteobacteria increasing in abundance from 32.3% in the control group up to 89.8% in the infected group, while Firmicutes and Actinobacteria significantly decreased in relative abundance from 23% and 37.8-2.4% and 1.1%, respectively. After LEfSe analysis, Acinetobacter was identified as the best biomarker for the parasite-exposed group. Parasite exposure also altered the expression of 935 host genes, highlighting genes involved in immune responses such as pathways related to Interleukins, MHCI and Interferons. Microbial transcripts, also showed significant changes upon parasite infection. Integration of the results revealed differential effects on the host induced directly by the parasite or indirectly by parasite-induced microbial shift.

conclusionsIntestinal microbiota and local host gene expression showed significant changes upon en enteromyxosis. The detected activation of the host immune response was not exclusively linked to the parasite infection but also to changes in microbiota, demonstrating the key role of the different components of the mucosal system during disease. These results provided different datasets of bacterial taxa and microbial and host transcripts that will allow a better understanding of host-microbiota-parasite interactions and can serve as starting points for studying and evaluating mucosal health in aquaculture during parasitosis or other diseases.

Indexed as

16S rRNA sequencingAquacultureHost–parasite interactionsIntestinal microbiotaMetataxonomicsMetatranscriptomeMyxozoanRNA sequencingSparus aurata

Identifiers

PMID40050956
PMCPMC11884135

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.